Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Daily Big Picture:Nifty Ends Below 9,000; Pharma Index Up 45% From its Lows

Author: Marketsmith India
by Marketsmith India
Posted: Apr 18, 2020

Today’s Action

Nifty, -1.3%; Sensex, -1.5%; Nifty Midcap, -1.4%; Nifty Smallcap, -0.6%; Model Portfolio, +0.9%

Market Pulse Confirmed Uptrend

Nifty opened on a flat note and quickly lost around 100 points and made an intraday low of 8,912. However, it pared some of its losses and closed slightly below 9,000. Nifty escaped distribution as today’s volume was lower than the previous session.

Barring Nifty Pharma (+2.8%) and Metal (+1.9%), all sectoral indices closed in the red. Nifty Pharma rallied ~45% from its lows. On the flip side, Nifty Realty (-4.9%), Media (-3.3%) and Financial Services (-3.1%) were the major decliners. The advance-decline ratio was in favor of advancers. Of 2,126 stocks traded, 952 advanced, 854 declined, and the remaining traded flat.

We continue to be very selective about taking any fresh positions. It is important that investors don’t play all their cards at once. We would suggest adopting an investment approach where you begin with a small allocation and increase it as and when the market advances further.

Without trying to predict and decode stories, we will take what the market gives us and continue to monitor unfolding conditions. Stocks with higher relative strength and superior fundamentals can do well. Some leading stocks have sharply corrected. Wait for them to put in at least a short period of consolidation and show a constructive breakout from that range. Buying without this period of constructive behavior into a straight upmove off the bottom, puts you at a risk of drawdown.

Key News

According to SIAM data, passenger vehicles sales for FY20 declined 18% whereas it declined 51% y/y for March. Commercial vehicles sales declined 29% for FY20 and 88% for March.

Dr Reddys Labs. (Nse) launched the blood cancer drug Invista in India. These tablets are used for the treatment of Chronic Myeloid Leukemia.

Bandhan Bank

  • s total deposits grew 32% y/y to Rs 57,073 in FY20. Retail deposits grew 34% in the same period and form 78.4% of the total deposits.

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. It is for educational purposes only.

Performance computations reflect a time-weighted rate of return and includes a brokerage of 0.5%. All holdings are rebalanced to equal rupee amounts daily. Dividends are not considered in computations. Percent gains and losses are calculated for all issues that remain on the "Current Holdings" at the end of the day. For stocks that were added to "Current Holdings", the basis used to calculate the percent change is the price noted when the issue appeared as a "Current Holdings" in MarketSmith India. For stocks that were removed, the selling price used to calculate the percent is the price note d when the issue appeared as "Removed" in the MarketSmith India. For more information, see our Legal disclosures here.

About the Author

MarketSmith India is an investment advisory product based on William O’Neil’s Can Slim method with model portfolio, pattern recognition, idea lists powered by institutional quality data

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Marketsmith India

Marketsmith India

Member since: Mar 04, 2020
Published articles: 43

Related Articles